Sanofi profits jump in first quarter
May 5, 2006Sales and Marketing
Sanofi-Aventis has recorded a major increase in its profits in the first three months of 2006, boosted by product growth …
AstraZeneca abandons diabetes drug over safety concerns
May 5, 2006Research and Development AstraZeneca, PPAR agonist
AstraZeneca is to abandon its late-stage diabetes drug Galida after new results raised doubts about its safety.Galida is a PPAR …
Frontline NHS staff enlisted in fight against flab
May 5, 2006The nation's increasing weight is to become top priority for frontline NHS staff in an effort to halt the rise …
AstraZeneca to co-market nanotechnology cancer drug
May 4, 2006Sales and Marketing
Groundbreaking nanotechnology is behind a new drug, which AstraZeneca and co-marketers Abraxis BioScience believe could be a major advance in …
Project management: from apprentice to master
May 3, 2006Research and Development, Sales and Marketing
When the three 'Apprentices' enter Mr. Sugars boardroom to explain why they made such a hash of their latest project, …
Is pharma fit for the future?
May 3, 2006Sales and Marketing
It's getting personal. While the pharma industry continues to debate the end of the blockbuster model, hardly a single clinician, …
Positive results halt trial of new Herceptin rival
May 3, 2006Research and Development
Better than expected results for a new drug for advanced breast cancer have led to trials being halted, in order …
Herceptin and the rise of patient power
May 3, 2006Sales and Marketing
The controversy surrounding Herceptin and its use in patients with early stage breast cancer has become a graphic illustration of …
Brands:looking at the bigger picture
May 3, 2006Sales and Marketing
While the prospect of a single-product company might seem attractive – no in-fighting over resource allocation, no conflicts of interest, …
‘Dawn of a new era’ as nurses and pharmacists take on full prescribing
May 3, 2006Trained nurses and pharmacists in England now have the power to prescribe virtually any medicine, which could end the need …
Herceptin set for approval in early breast cancer
April 28, 2006Sales and Marketing
Herceptin, the breast cancer drug at the centre of a long-running controversy could soon be available to thousands more women …
Helping doctors hit moving targets
April 26, 2006Introduced in April 2004, the new General Medical Services contract (nGMS) was hailed as a revolutionary new way of paying …
Ex-Pfizer Stafford launches patient communication consultancy
April 26, 2006Medical Communications patients
The needs of patients are being forgotten or over-looked by pharmaceutical companies, according to a newly launched consultancy called Patient …
Make small changes to ‘add years to your life’ urges government
April 26, 2006Everyday, simple choices could be the key to a healthier lifestyle according to new government-backed research published by Cambridge University. …
Osteoporosis drug Evista can prevent breast cancer
April 26, 2006Sales and Marketing
A new study of Lilly's Evista suggests it could help prevent postmenopausal women developing breast cancer.A major new study of …
Biotech buy helps Pfizer expand neuroscience research
April 26, 2006Research and Development, Sales and Marketing Pfizer
Pfizer is to buy Californian Rinat Neuroscience, a biotech company which specialises in developing therapeutic proteins to treat central nervous …
Companies share secrets to reduce unforeseen phase I problems
April 26, 2006Research and Development
Eight of the industry's leading companies have begun work on a unique new project to help overcome one of the …
UK pharma industry unites to take the Code to customers
April 26, 2006Research and Development
Companies from across the UK pharma industry have come together in an unprecedented campaign to promote awareness of its code …
MPs set to probe health service finances as ‘crisis’ continues
April 26, 2006MPs look set to launch an inquiry into the continuing problems in the NHS, as job cuts and fears of …
AstraZeneca celebrates success of FMCG marketer recruitment
April 26, 2006Sales and Marketing
Targeted campaign pays off as the number of candidates joining the company from outside the pharma industry increases by five-fold …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
